1. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20(10): 795-820.
2. Feske SK. Ischemic Stroke. Am J Med 2021; 134(12): 1457-64.
3. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci 2020; 21(20): 7609.
4. Herpich F, Rincon F. Management of Acute Ischemic Stroke. Crit Care Med 2020; 48(11): 1654-63.
5. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007; 38(3): 1091-6.
6. Freire MAM. Natural compounds in neuroprotection and nervous system regeneration: A narrative review. Regen Med Rep 2025; 3(3): 115-23.
7. Singh D. Neuropharmacological Aspects of Crocus sativus L.: A Review of Preclinical Studies and Ongoing Clinical Research. CNS Neurol Disord Drug Targets 2015; 14(7): 880-902.
8. Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, A MT. The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed 2015; 5(5): 376-91.
9. EFFECTS Trial Collaboration. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2020; 19(8): 661-9.
10. Elkind MSV, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, et al. Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial. Neurology 2020; 95(8): e1091-e104.
11. Asadollahi M, Nikdokht P, Hatef B, Sadr SS, Sahraei H, Assarzadegan F, et al. Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial. J Ethnopharmacol 2019; 238: 111833.
12. Gudarzi S, Jafari M, Pirzad Jahromi G, Eshrati R, Asadollahi M, Nikdokht P. Evaluation of modulatory effects of saffron (Crocus sativus L.) aqueous extract on oxidative stress in ischemic stroke patients: a randomized clinical trial. Nutr Neurosci 2022; 25(6): 1137-46.
13. Yousefi M, Sasannezhad P, Rakhshande H, Doosti H, Saki A, Baghestani Z, et al. Effect of Carthamus tinctorius L. (Safflower) on National Institute of Health Stroke Scale Scores of Ischemic Stroke Patients: A Pilot Clinical Trial. Trad Integr Med 2022; 7(2): 209-16.
14. Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther 2020; 20(1): 333.
15. Shahbaz K, Chang D, Zhou X, Low M, Seto SW, Li CG. Crocins for Ischemic Stroke: A Review of Current Evidence. Front Pharmacol 2022; 13: 825842.